Suspension of trading

CureVac

Stocks

Delayed Nasdaq 16:00:00 2026-01-05 EST			5-day change	1st Jan Change
4.660 ^USD	-0.21%		-.--%	+3.10%

04-15	Evotec Taps CureVac Executive as COO	MT
01-06	CureVac ends coverage after BioNTech acquisition

Published on 11/28/2025 at 03:23 am EST

S&P Capital IQ

Presenter Speech
Mehdi Shahidi (Executives)

Welcome, everyone, to this Extraordinary General Meeting of Shareholders of CureVac N.V. My name is Dr. Mehdi Shahidi. I'm a member of the company's

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

04-15	Evotec Taps CureVac Executive as COO	MT
01-06	CureVac ends coverage after BioNTech acquisition
01-05	CureVac N.V.(NasdaqGM:CVAC) dropped from NASDAQ Composite Index	CI
01-01	Evotec SE Announces Executive Changes	CI
12-18	European Stocks Set to Close Higher in Thursday Trading; ECB Maintains 3 Key Interest Rates; England Cuts Rate by Quarter Point	MT
12-18	BioNTech SE completed the acquisition of CureVac N.V. from dievini Hopp BioTech holding GmbH & Co. KG, KfW and others.	CI
12-18	BioNTech Closes CureVac Acquisition	MT
12-18	BioNTech Wraps Up Exchange Offer to Buy CureVac	MT
12-18	BioNTech Wraps Up Exchange Offer to Buy CureVac	MT
12-18	Biontech closes acquisition of CureVac	RE
12-17	CureVac N.V.(NasdaqGM:CVAC) dropped from S&P Global BMI Index	CI
12-03	Biontech achieves minimum condition in CureVac exchange offer	RE
12-03	BioNTech Says Minimum Condition Met in CureVac Exchange Offer	MT
12-02	CureVac N.V.(NasdaqGM:CVAC) dropped from NASDAQ Biotechnology Index	CI
11-28	CureVac N.V. - Shareholder/Analyst Call